Besides, as demonstrated in Supplementary Figure S16b, STAT2 expression was depicted to had positive correlation CTL infiltration levels in endometrial carcinoma (r = 0.192, p = 6.61e−6), neuroblastoma (r = 0.229, p = 5.22e−6), metastatic melanoma (r = 0.356, p = 6.28e−11), and triple negative breast cancer (r = 0.360, p = 1.58e−8). This evidence concerns the gene STAT2 and triple-negative breast carcinoma.